Author Archive

Towards a sustainable European market for off-patent biologics

Posted by:

As pioneers with regards to the regulatory approval and use of biosimilars, the EU is now reaping the economic benefits, with increased patient access and healthcare system efficiencies generated through competition on the one hand and continued innovation on the other – an essential equilibrium for securing a sustainable future for the European biologics market.

However, the increasing focus on maximizing short-term savings and the high diversity of policies governing the daily practice of off-patent biologics may eventually undermine this goal.

It is imperative to ask: How should the policy ...

Continue Reading →
0

Taiwan is accelerating towards leadership of the Fourth Industrial Revolution

Posted by:

Professor Meir Pugatch spoke last week at the forum “How to Accelerate Taiwan Biomedical Policy Momentum as an Asia-Pacific Biomedical R&D Hub” hosted by the International Research-based Pharmaceutical Manufacturers Association (IRPMA), and included the Vice President of Taiwan Chien-Jen Chen and Minister Ming-Hsin Kung from the Executive Yuan, as well as leading figures from Taiwan’s Government, academia and industry.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to, and remaining challenges in, Taiwan’s path to leadership in global ...

Continue Reading →
0

The EU Orphan Regulation: A success story in driving R&D of orphan medicines in the EU – but what about access?

Posted by:

Pugatch Consilium is today releasing a new study – Benchmarking Success: Evaluating the Orphan Regulation and its impact on patients and rare disease R&D in the European Union.

Within the context of the European Commission’s Evaluation of the legislation on medicines for children and rare diseases, the study examines whether the EU Orphan Regulation has accomplished its aim of incentivising the development and introduction of new therapies for rare diseases onto the EU market, and explores some of the current and ...

Continue Reading →
0

Positioning Ireland as a global innovation leader in the 4th Industrial Revolution

Posted by:

Professor Pugatch delivered a keynote presentation at the 25th Annual Conference of the Irish Pharmaceutical Healthcare Association (IPHA) at Dublin, Ireland, themed ‘Patient Care, Powered By Innovation’.

In the field of professional boxing, Ireland was and remains a global superpower and a role model. Yet in the field of biopharmaceutical innovation, Ireland does not step into the ring of greats:

  • Despite retaining the reputation of a global leader in advances biopharmaceutical manufacturing – with €10 billion invested over the past decade – ...
Continue Reading →
0

Leveraging Resources to Generate Outputs and Lead the Global Biotech Innovation – Policy is Key!

Posted by:

Most, if not all countries today view biotechnology as a strategic area for economic and social development and growth. Most, if not all countries today wish to leverage existing resources such as academic and research facilities and human capital to create a globally-competitive knowledge-based economy. Some have succeeded where others failed. Why?

 

Earlier last week Professor Meir Pugatch moderated the Global Leadership Forum at the BIO International Convention that was held at Boston, MA. The panel, titled “Can Boston’s DNA be ...

Continue Reading →
0

A New Era For Russian Biotechnology In 2030 – Remains To Be Seen And Proven

Posted by:

Professor Meir Pugatch spoke at the St. Petersburg International Economic Forum (SPIEF) in the panel: “Life Sciences in 2030: A New Era for Biotechnology” which took place on May 26, 2018 and included the Deputy Ministers of the Ministries of Health, Industry and Trade, and Agriculture of the Russian Federation, as well as Senior Executives of top MNCs in the private sector. Prof. Pugatch presented key highlights of Pugatch Consilium’s research concerning the enabling conditions for developing a competitive bioeconomy ...

Continue Reading →
0

Towards a Sustainable European Market for Off-Patent Biologics

Posted by:

Professor Meir Pugatch spoke yesterday at the event: “Building a sustainable Policy Framework for Biologics and Biosimilar Medicines in Europe”, which took place at the European Parliament, and included members from the European Commission and organizations such as Medicines for Europe, ESMO and EPF. Professor Pugatch presented the findings of a new study by Pugatch Consilium, commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

With 38 biosimilar medicines approved and marketed and hundreds of clinical trials on ...

Continue Reading →
0

BIO 2017

Posted by:

Professor Meir Pugatch and Dr. David Torstensson are speaking today at the BIO international convention held in San Diego, CA. Sponsored by the Biotechnology Innovation Organization, the annual convention hosts more than 16,000 attendees from over 70 countries.

 

Yesterday Professor Pugatch participated in a high level discussion within the What in the World Matters? The Challenge of Spurring Innovation in Global Markets panel, which focused on the relatively slow uptake of biotech innovation in economies outside the US, and ...

Continue Reading →
0

¿Cómo ser más competitivo? How to increase competitiveness – a Semana Magazine interview with Ma’ayan Laufer, Senior Consultant at Pugatch Consilium

Posted by:

Today Semana Magazine, Colombia’s leading and international prize-winning magazine, published the article: ¿Cómo ser más competitivo? (How to increase competitiveness?) following an exclusive interview with Ma’ayan Laufer, a senior consultant at Pugatch Consilium. The interview took place last week, right after the launch of Pugatch Consilium’s recent report: “Challenges and Opportunities – Developing the Biotechnology Sector in Colombia” at the Bionovo conference in Bogotá, Colombia [BioNovo]

The key findings of the report, that Colombia could see over 100 new clinical ...

Continue Reading →
0